Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S3BF
|
|||
| Former ID |
DNCL001694
|
|||
| Drug Name |
Pegadricase
|
|||
| Indication | Gout [ICD-11: FA25; ICD-10: M10] | Phase 1 | [1] | |
| Company |
3SBio
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H24N2O6
|
|||
| Canonical SMILES |
COCCOC(=O)CCC(=O)NCCCCC(C(=O)O)N
|
|||
| InChI |
1S/C13H24N2O6/c1-20-8-9-21-12(17)6-5-11(16)15-7-3-2-4-10(14)13(18)19/h10H,2-9,14H2,1H3,(H,15,16)(H,18,19)/t10-/m0/s1
|
|||
| InChIKey |
PNFORBBPPMQASU-JTQLQIEISA-N
|
|||
| CAS Number |
CAS 1040753-26-1
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Uric acid (URA) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018169) | |||
| REF 2 | Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies. J Rheumatol. 2002 Sep;29(9):1942-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.